Gennova to use mRNA tech to develop vaccines for Zika, tuberculosis

Khyati Shah10 Aug, 2021News

Gennova Biopharmaceuticals, a subsidiary of Pune-headquartered Emcure Pharmaceuticals, is not only developing India?s first indigenous messenger ribonucleic acid (mRNA) Cov?id-19 vaccine, but also plans to leverage the platform to develop vaccines for the Zika virus, herpes zoster (shingles), and tuberculosis (TB). ?The mRNA platform is disease-agnostic.